MK-677
MK-677 (ibutamoren) is a non-peptide, orally active agonist of the ghrelin receptor and a growth-hormone secretagogue.
Growth-hormone secretagogues, GHRH analogues and IGF-related research peptides. Compare GHRP, GHRH and IGF compound prices across vendors by $/mg. Prices normalized to dollars per milligram across 45 vendors.
| Peptide | Vendors | Lowest $/mg |
|---|---|---|
| MK-677 | 4 | $2.27/mg |
| GHRP-2 | 11 | $2.90/mg |
| GHRP-6 | 11 | $2.90/mg |
| Ipamorelin | 40 | $3.90/mg |
| CJC-1295 | 26 | $4.30/mg |
| Tesamorelin | 31 | $4.30/mg |
| Sermorelin | 28 | $5.50/mg |
| Hexarelin | 14 | $6.40/mg |
| MGF | 8 | $10.0/mg |
| PEG MGF | 15 | $12.6/mg |
| IGF-1 LR3 | 19 | $19.7/mg |
| IGF-1 DES | 5 | $25.8/mg |
| CJC-1295 (No DAC) | 2 | $29.5/mg |
MK-677 (ibutamoren) is a non-peptide, orally active agonist of the ghrelin receptor and a growth-hormone secretagogue.
GHRP-2 (pralmorelin) is a synthetic growth-hormone secretagogue; in Japan it has been used as a diagnostic agent for assessing growth-hormone status.
GHRP-6 is a synthetic peptide belonging to the growth-hormone-secretagogue class, acting at the ghrelin receptor.
Ipamorelin is a synthetic pentapeptide and selective growth-hormone secretagogue that acts at the ghrelin receptor.
CJC-1295 is a synthetic analogue of growth-hormone-releasing hormone (GHRH), a modified form of the GHRH(1-29) fragment with an extended half-life.
Tesamorelin is a synthetic form of growth-hormone-releasing hormone (GHRH) comprising the full 44-amino-acid sequence with an added stabilizing group.
Sermorelin is a synthetic peptide corresponding to the 1–29 fragment of growth-hormone-releasing hormone (GHRH).
Hexarelin (examorelin) is a synthetic hexapeptide and growth-hormone secretagogue that acts as an agonist of the ghrelin receptor.
MGF (mechano growth factor) is a naturally occurring 24-amino-acid peptide derived by cleavage from insulin-like growth factor 1 (IGF-1).
PEG-MGF is a pegylated (polyethylene-glycol-conjugated) form of mechano growth factor (MGF), a peptide derived from IGF-1, formulated for extended stability.
IGF-1 LR3 is a synthetic long-acting analogue of insulin-like growth factor 1 (IGF-1), a hormone structurally similar to insulin.
IGF-1 DES is a truncated analogue of insulin-like growth factor 1 (IGF-1) lacking the first three N-terminal amino acids.